November 20th 2024
New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Cover Story: Repeat antenatal corticosteroids: A time for caution
August 1st 2002While a single course of antenatal corticosteroids improves neonatal outcomes among infants born prematurely, the efficacy and safety of repetitive courses of ACS (including rescue dosing) is less clear. In the absence of adequate data to support a policy of repetitive dosing of ACS, such therapy should only be used as part of well-designed clinical trials.
Read More
Cover Story: Fetal growth restriction: an evidence-based approach--Part II
July 1st 2002Which small-for-gestational age fetuses are at an increased risk for irreversible perinatal complications and death? Having emphasised the importance of early diagnosis of FGR in Part I, the authors now focus on antepartum surveillance and assess the evidence for various management strategies.
Read More
CME: Combating the silent chlamydia epidemic
April 1st 2002Early diagnosis and treatment could drastically reduce the high medical, psychosocial, and economic costs of chlaymydial infections. So why are screening rates so low--especially in disproportionately affected younger women--and what can we do about it?
Read More
Cover Story: Doppler evaluation of the ovary
March 1st 2002Transvaginal color Doppler sonography has revolutionized morphological evaluation of the ovary, unveiling heretofore small, unseen tumor-feeding vessels. But while ovarian blood flow data can provide insights into tumor pathology, TVS cannot stand alone as a diagnostic tool.
Read More
Cover Story: Doppler evaluation of the ovary
March 1st 2002Transvaginal color Doppler sonography has revolutionized morphological evaluation of the ovary, unveiling heretofore small, unseen tumor-feeding vessels. But while ovarian blood flow data can provide insights into tumor pathology, TVS cannot stand alone as a diagnostic tool.
Read More